佰仁醫療(688198.SH):擬購買土地使用權並投資建設項目
格隆匯2月11日丨佰仁醫療(688198.SH)公佈,公司根據發展戰略規劃,擬參與競拍以掛牌方式取得昌平新城東區(南邵組團)1201街區CP00-1201-0036地塊的國有建設用地使用權,並在取得上述國有土地使用權後投資建設“佰仁醫療-艾佰瑞產業基地項目”(暫定名稱,以有關部門最終備案名稱為準)。該土地用途為M1一類工業用地,土地面積約為19,286.592平方米。公司擬使用不超過人民幣6,000.00萬元購買該土地使用權(土地具體位置、土地面積和交易金額等以實際出讓文件為準)。
佰仁醫療-艾佰瑞產業基地項目”分期建設,本次投資為項目一期,投資金額不超過人民幣2.5億元(含土地出讓金)。項目二期將根據一期建設情況、公司業務發展情況以及其他外部因素綜合判斷,另行決策並按照規定進行信息披露,最終投資金額以項目建設實際投入為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.